SBIR/STTR Research Award

Rapid No-Spin Chlamydia RNA Extraction via Filtering, Lysis and Monolith Binding

Award identifier 4310c570ea0d7a04e7846dca3f2527113db5f9ea5c5058ab3f4570c2f5123be3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$600,000

Program and phase

SBIR · Phase I

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
WAVE 80 BIOSCIENCES, INC.
Proposal award date
2014-02-15
Contract end date
2016-01-31
UEI
XDG6MCTKJEW7
Solicitation number
PA10-123
Topic code
NIAID

Research abstract

DESCRIPTION provided by applicant This application addresses the urgent need for expanded screening and test and treat programs for Chlamydia trachomatis CT through the development of a fast straightforward sample preparation method CT infection which is often asymptomatic in female patients can result in pelvic inflammatory disease and irreversible infertility in the infected individual as well as blindness in infants born to infected mothers CT infection can be readily resolved through a short course of antibiotics but achieving optimal patient outcomes depends on identifying infection and prescribing treatment within a single visit to a doctorandapos s office hospital or clinic the andquot test and treatandquot approach to infectious disease care Multiple studies have shown current rapid CT antigen tests to exhibit such poor sensitivity as to have almost no value in clinical decision making In contrast both the sensitivity and the specificity of nucleic acid testing for CT infection typically exceed With increasing availability and low cost of compact thermocyclers and other emerging nucleic acid testing technologies smaller clinics are increasingly well positioned to run the amplification and detection steps in CT nucleic acid testing Yet the requisite preparation of vaginal swab and urine samples for subsequent CT nucleic acid testing including lysis filtering and extraction and elution of bacterial RNA and DNA is a barrier to widespread adoption of CT nucleic acid testing outside of sophisticated laboratories This application seeks to enable expanded access to CT nucleic acid testing through the development of high performance fully automated CT sample preparation in an inexpensive disposable cartridge The usage procedure consists of simply placing a urine or vaginal swab sample in a small cup which attaches to the cartridge Slit capillary array fluidic actuator SCAFA chips an innovative technology recently developed by the Applicant Organization are built into the disposable cartridge and drive all sample and reagent transport steps entailed in a high extraction efficiency sample preparation process The extraction process will leverage an innovative fully cartridge integrated no centrifugation soli phase extraction method using porous polymer monoliths within short glass capillaries tuned to have optimal porosity for efficient capture of a nucleic acid target without clogging The sample preparation process executed within the cartridge also includes pre extraction steps of sample metering filtering CT from sample lysing CT on the filter and elution from the filter Sample in to results out turnaround time is minutes This Phase I project is organized around two specific aims Specific Aim focuses on the sample prep moduleandapos s front end including metering and lysing Specific Aim focuses on high yield extraction in the porous polymer monolith including monolith composition and capture elution chemistry The two Aims collectively establish the feasibility of the high performance low cost CT sample preparation cartridge laying groundwork for full development in Phase II PUBLIC HEALTH RELEVANCE Chlamydia trachomatis CT is the most commonly reported STD domestically and asymptomatic infections in women lead to pelvic inflammatory disease and infertility undetected infections in pregnant women lead to infant conjunctivitis and blindness The only sensitive and specific CT tests are nucleic acid tests NATs which are not available on site at the clinics that high risk patients visit because NATs are subcontracted to consolidated testing centers the turnaround time causes loss to follow up in many patients who remain untreated The proposed rapid automated fully enclosed sample preparation system for nucleic acid extraction from urine or vaginal swab samples will enable these clinics to run NATs on site with compact nucleic acid testing systems expanding access to accurate CT diagnosis and reducing disparities in CT infection

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

14 SBIR/STTR records share this UEI (2003–2023). Reported award amounts total $6,971,568. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.